REVIVE (Response to the Ebola Virus Vaccine)
REVIVE (Response to the Ebola Virus Vaccine)
Active, not recruiting · NCT05992480 · Registry updated 2026-06-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| REVIVE (Response to the Ebola Virus Vaccine) | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Active, not recruiting | Phase 4 | 2026-06-04 | NCT05992480 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kenema Government Hospital | 2 |
| Merck Sharp & Dohme LLC | 650 |
| Tulane University | 51 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kenema Government Hospital | Kenema | Sierra Leone | 1 |